期刊文献+

BRD4拮抗剂GSK525762A对SUP-B15细胞增殖与凋亡的影响及其可能的作用机制 被引量:1

Effect of BRD4 Inhibitor GSK525762A on Proliferation and Apoptosis of SUP-B15 Cells In Vitro and Its Possible Mechanism
下载PDF
导出
摘要 目的:探讨BRD4拮抗剂GSK525762A对费城染色体阳性急性淋巴细胞白血病SUP-B15细胞株增殖、凋亡的影响及其作用机制。方法:选择不同浓度的GSK525762A处理SUP-B15细胞,采用CCK-8法检测细胞活力并绘制增殖抑制曲线,应用Annexin V/7-AAD双染流式细胞术检测细胞存活与凋亡,定量PCR检测C-MYC、CDK6、BCL2的转录变化。结果:GSK525762A能显著抑制SUP-B15细胞增殖,且具有量-效关系和时-效关系。GSK525762A能够诱导SUP-B15细胞凋亡;GSK525762A能够使抑凋亡基因C-MYC、CDK6、BCL2表达减低。结论:GSK525762A能抑制SUP-B15细胞增殖并诱导其凋亡,其机制主要与下调C-MYC、CDK6、BCL2转录有关。 Objective:To investigate the effect of BRD4 inhibitor GSK525762 A on the proliferation and apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia SUP-B15 cells and its mechanism.Methods:SUP-B15 cells were treated with different concentration of GSK525762 A,the proliferation-inhibition curve was assayed and plotted by CCK-8 method,the cell viability and apoptosis were detected by flow cytometry with Annexin V and 7-AAD staining.The transcripts of anti-apoptotic genes C-MYC,CDK6 and BCL-2 were detected by real-time PCR.Results:GSK525762A could inhibit significantly SUP-B15 cell proliteration in dose-and time-dependent manner;GSK525762A treatment could induce apoptosis of SUP-B15 cells.The levels of C-MYC,CDK6 and BCL-2 mRNA transcripts in SUPB15 cells were reduced in GSK525762A-treated group.Conclusion:The GSK525762 A can remarkably inhibit proliferation and induce apoptosis of SUP-B15 cells.The down-regulation of apoptosis-related genes C-MYC,CDK6 and BCL-2may be involved in the process of apoptosis.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2016年第6期1654-1658,共5页 Journal of Experimental Hematology
基金 国家自然科学基金(81471580 81272206) 江苏省普通高校研究生科研创新计划(SJEE14-0199)
关键词 BRD4 GSK525762A 急性淋巴细胞白血病 SUP-B15细胞 BRD4 GSK525762A acute lymphoblastic leukemia SUP-B15 cell
  • 相关文献

参考文献2

二级参考文献21

  • 1Dawson MA,Prinjha RK,Dittmann A,et al.Inhibition of BET recruitment to chromatin as an effective treatment for MLLfusion leukaemia[J].Nature,2011,478(7370):529-533.
  • 2Eguchi M,Eguchi-Ishimae M,Greaves M.Molecular pathogenesis of MLL-associated leukemias[J].Int J Hematol,2005,82(1):9-20.
  • 3Joh T,Kagami Y,Yamamoto K,et al.Identification of MLL and chimeric MLL gene products involved in 11q23 translocation and possible mechanisms of leukemogenesis by MLL truncation[J].Oncogene,1996,13(9):1945-1953.
  • 4Pajuelo-Gámez JC,Cervera J,Garcia-Casado Z.MLL amplification in acute myeloid leukemia[J].Cancer Genet Cytogenet,2007,174(2):127-131.
  • 5Meyer C,Schneider B,Jakob S,et al.The MLL recombinome of acute leukemias[J].Leukemia,2006,20(5):777-784.
  • 6Zeng L,Zhou MM.Bromodomain:an acetyl-lysine binding domain[J].FEBS Lett,2002,513(1):124-128.
  • 7Dey A,Chitsaz F,Abbasi A,et al.The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis[J].Proc Natl Acad Sci U S A,2003,100(15):8758-8763.
  • 8Maruyama T,Farina A,Dey A,et al.A Mammalian bromodomain protein,brd4,interacts with replication factor C and inhibits progression to S phase[J].Mol Cell Biol,2002,22(18):6509-6520.
  • 9Jang MK,Mochizuki K,Zhou M,et al.The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase Ⅱ-dependent transcription[J].Mol Cell,2005,19(4):523-534.
  • 10Zuber J,Shi J,Wang E,et al.RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia[J].Nature,2011,478(7370):524-528.

共引文献3

同被引文献17

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部